Anticoagulant Drug Heparin Recalled for Possible Contamination

Lots of the anticoagulant medicine Heparin have been recently recalled because of possible contamination. According to a news report in The Los Angeles Times, pharmaceutical company B. Braun Medical Inc. issued the recall for seven lots of the drug because of the presence of oversulfated chondroitin sulfate (OSCS).

It is the responsibility of pharmaceutical manufacturers to put safe, uncontaminated products into the stream of commerce and to timely notify the public and appropriate governmental agencies of any potential dangers associated with the use of their products. No drug is devoid of side effects. Minor side effects are quite common and the risks of these side effects are often outweighed by the benefits of the medication. However, when a drug causes serious or fatal side effects, the general public and the healthcare community must be properly warned of the risks and contraindications pertaining to the use of the drug.

A drug manufacturer may be held liable for the injuries, damages and losses their products cause. This is especially true when patients are unaware that the drugs they are taking could put them in danger of a serious health risk or even death.

The New Jersey pharmaceutical liability attorneys at Blume Forte have handled numerous claims involving pharmaceutical negligence. If a dangerous drug has harmed you or a loved one, please call our offices at 973-635-5400 for a no-cost consultation and comprehensive evaluation of your potential unsafe drug claim.

Related Articles: